Pikatan, N. W., Liu, Y., Bamodu, O. A., Hsiao, M., Hsu, W., Haryana, S. M., . . . Yeh, C. (2020). Aberrantly expressed Bruton's tyrosine kinase preferentially drives metastatic and stem cell-like phenotypes in neuroblastoma cells. Cellular Oncology (2211-3428), 43(6), 1067. https://doi.org/10.1007/s13402-020-00541-5
Chicago Style (17th ed.) CitationPikatan, Narpati Wesa, Yen-Lin Liu, Oluwaseun Adebayo Bamodu, Michael Hsiao, Wen-Ming Hsu, Sofia Mubarika Haryana, Sutaryo, Tsu-Yi Chao, and Chi-Tai Yeh. "Aberrantly Expressed Bruton's Tyrosine Kinase Preferentially Drives Metastatic and Stem Cell-like Phenotypes in Neuroblastoma Cells." Cellular Oncology (2211-3428) 43, no. 6 (2020): 1067. https://doi.org/10.1007/s13402-020-00541-5.
MLA (9th ed.) CitationPikatan, Narpati Wesa, et al. "Aberrantly Expressed Bruton's Tyrosine Kinase Preferentially Drives Metastatic and Stem Cell-like Phenotypes in Neuroblastoma Cells." Cellular Oncology (2211-3428), vol. 43, no. 6, 2020, p. 1067, https://doi.org/10.1007/s13402-020-00541-5.